Cytek Biosciences Inc (CTKB)
6.095
-0.08
(-1.38%)
USD |
NASDAQ |
May 17, 16:00
6.095
0.00 (0.00%)
After-Hours: 20:00
Cytek Biosciences Net Income (Quarterly): -6.169M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -6.169M |
| December 31, 2023 | 5.503M |
| September 30, 2023 | -6.456M |
| June 30, 2023 | -4.388M |
| March 31, 2023 | -6.807M |
| December 31, 2022 | 3.529M |
| September 30, 2022 | 1.666M |
| June 30, 2022 | -0.598M |
| March 31, 2022 | -2.021M |
| Date | Value |
|---|---|
| December 31, 2021 | -1.191M |
| September 30, 2021 | 1.42M |
| June 30, 2021 | 2.67M |
| March 31, 2021 | 0.102M |
| December 31, 2020 | 5.599M |
| September 30, 2020 | 6.54M |
| June 30, 2020 | 8.111M |
| March 31, 2020 | -0.839M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-6.807M
Minimum
Mar 2023
8.111M
Maximum
Jun 2020
0.3924M
Average
0.102M
Median
Mar 2021
Net Income (Quarterly) Benchmarks
| Ainos Inc | -3.315M |
| OpGen Inc | -4.063M |
| Zomedica Corp | -9.16M |
| LENSAR Inc | -2.157M |
| Eargo Inc (DELISTED) | -17.33M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 44.86M |
| Total Expenses (Quarterly) | 55.59M |
| EPS Diluted (Quarterly) | -0.05 |
| Enterprise Value | 534.09M |
| Gross Profit Margin (Quarterly) | 51.30% |
| Profit Margin (Quarterly) | -13.75% |
| Earnings Yield | -1.48% |
| Normalized Earnings Yield | -1.475 |